JAK2 and neoplasm: Given that JAK2 and STAT4 are aligned with effective CTL activation and better clinical outcomes, their suppression by E7 suggests a potential mechanism of viral immune evasion that may not only support HPV persistence but may also contribute to an immunosuppressive environment, facilitating tumor progression [45,51].